|Videos|November 17, 2016

Special Reports

  • NSCLC (Issue 11)
  • Volume 4
  • Issue 2

Clinical Trials Exploring Bevacizumab in NSCLC

Catherine Shu, MD, medical oncologist, Division of Hematology/Oncology, Columbia University Medical Center, discusses two clinical trials exploring the use of bevacizumab (Avastin) in patients with non-small cell lung cancer.


Latest CME